Search results for: 'rare ran'

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides innovation insights across cell and gene therapy advances. The TOE also encompasses recent therapy developments for neuropsychiatric, rare, and infectious diseases. The research covers recent advances in vaccines and biomanufacturing platforms.The Life ...

The race to provide 5G in some areas of the world has driven growth rates for 5G network infrastructure to rise above historical averages. However, 2024 saw slowing growth as 5G coverage in these countries and regions became more ubiquitous. This does not mean investment in 5G networks is done; there is still much work to be done in all areas of 5G...

20 Dec 2024  |  Global  |  Market Research

Telecom DC Power Systems Industry, Global, 2024-2033

Demand for DC Power Systems is Experiencing Transformational Growth Due to Advances in 5G and IoT Alongside RAN Site Modernization and Edge Expansion

Infographics

×

The global telecom DC power systems market is highly mature, generating revenue worth $4.6 billion in 2023. The market, however, saw a sharp revenue decline the same year because of several factors, including decreased growth in the overall RAN industry, a slowdown in 5G construction and spending, excess inventory built in response to supply chain ...

In 2024, the life science (LS) industry s focus on precision health will intensify. LS companies will augment their omics-based research capabilities and increasingly deploy AI and bioinformatics to discover personalized therapies. Partnerships between pharmaceutical companies and technology vendors will multiply, to support innovation in drug disc...

12 Aug 2020  |  North America  |  Market Research

New Drug Development for Rare Pediatric Disorders Sustaining High Growth in the Global Orphan Drugs Market, 2019–2025

AI-powered Early Disease Diagnosis and Drug Repurposing will Create New Growth Opportunities

Infographics

×

Key Issues Addressed

Rare diseases have been an increasing area of focus as three waves have converged in recent years: genomic research and innovations becoming mainstream; the forthcoming regulatory policies and financial incentives put in place by the federal agencies; and the increasingly patient-centric and coordinated efforts of patient advocacy groups, caregive...

This issue of High-Tech Materials Technology Opportunity Engine (TOE) profiles significant advancements in nanotechnology for various enhanced industrial applications. The featured innovations include Photocatalytic Conversion of Methane to Clean Hydrogen and Carbon Nanotubes, Stable Carbon Nanotube Dispersions for Enhanced Battery Performance, Adv...

Demand for electric motors (e-motor) has skyrocketed in recent years, driven by the growing shift toward electric vehicles (EVs), stricter carbon emission regulations, government incentives, and advancements in battery technology. Currently, interior permanent magnet synchronous motors (IPMSM) dominate most of the EV traction motor market, thanks t...

Electronic and battery waste should be considered as an important source for the recovery of crucial precious metals including Lead, Lithium, Nickel, Cadmium, Cobalt, and Copper. The recovery of rare earth metals from end-of-life electronics and batteries will reduce the burden on landfills and will also prevent leaching of hazardous compounds into...

24 Jul 2020  |  North America  |  Market Research

Curative Oncology and Rare Disease Therapies Transforming the Global Biologics Market, 2020–2024

Strategic Collaborations with Specialty Bio-CDMOs will Continue to Drive Growth Opportunities in Antibody-drug Conjugates and Gene Therapies

Infographics

×

Key Issues Addressed

With this research service, Frost & Sullivans Transformational Health team provides critical insights into the global biologics industry highlighting the growth opportunities, market revenue segmentation, and technology trends influencing its growth. The global biologics market covered in this study includes 4 major segments – antibody therapies, r...